Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Polyphor AG
  6. News
  7. Summary
    POLN   CH0106213793

POLYPHOR AG

(POLN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about POLYPHOR AG
10/29Polyphor, EnBiotix Shareholders Green-Light Merger, Name Change
MT
10/29Polyphor AG Announces Executive Changes
CI
10/15POLYPHOR : Exempted From Public Tender Offer Obligation In Merger With EnBiotix
MT
10/14Polyphor to Seek Acquisitions
CI
09/27Polyphor AG Announces Executive Changes
CI
09/10POLYPHOR : Wraps Up Sale Of Inhaled Murepavadin To EnBiotix
MT
09/01POLYPHOR : Signs All-Stock Merger Deal With Rare Disease Company EnBiotix
MT
09/01Polyphor AG signed a merger agreement to acquire EnBiotix, Inc.
CI
08/04POLYPHOR : Fails In Late-Stage Trial For Breast Cancer Combo Treatment
MT
08/03Polyphor Provides Final Update on the Phase III FORTRESS Study of Balixafortide in Pati..
CI
07/30POLYPHOR : To Layoff 20 Staff After Negative Results From Breast Cancer Treatment Study
MT
07/16POLYPHOR : to Halt Study of Breast Cancer Combo, Restructure by Up to 29 Positions
MT
07/16Polyphor AG Provides Update on the Future of the Fortress Study of Balixafortide and An..
CI
06/28POLYPHOR : Fails in Late-Stage Breast Cancer Drug Trial; Shares Tank 52%
MT
06/28POLYPHOR : provides update on the Phase III FORTRESS study of balixafortide in patients wi..
EQ
More most relevant news
All news about POLYPHOR AG
10/29Polyphor, EnBiotix Shareholders Green-Light Merger, Name Change
MT
10/29Polyphor AG Announces Executive Changes
CI
10/15POLYPHOR : Exempted From Public Tender Offer Obligation In Merger With EnBiotix
MT
10/14Polyphor to Seek Acquisitions
CI
09/27Polyphor AG Announces Executive Changes
CI
09/10POLYPHOR : Wraps Up Sale Of Inhaled Murepavadin To EnBiotix
MT
09/02GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
09/01POLYPHOR : Signs All-Stock Merger Deal With Rare Disease Company EnBiotix
MT
09/01Polyphor AG signed a merger agreement to acquire EnBiotix, Inc.
CI
08/04POLYPHOR : Fails In Late-Stage Trial For Breast Cancer Combo Treatment
MT
More news
News in other languages on POLYPHOR AG
12/02AKTIEN SCHWEIZ SCHLUSS : SMI mit Omikron-Sorgen auf Talfahrt
12/01AKTIEN SCHWEIZ SCHLUSS : SMI schliesst deutlich höher
11/25BOURSE ZURICH : le SMI poursuit sa progression à l'approche de la mi-journée
11/25BOURSE ZURICH : ouverture en hausse dans le sillage de mercredi
11/15AKTIEN SCHWEIZ SCHLUSS : Kaum verändert an ruhigem Handelstag
11/11BOURSE ZURICH : le SMI retrouve tout son élan à l'approche de la mi-journée
11/10AKTIEN SCHWEIZ SCHLUSS : SMI schliesst dank defensiven Schwergewichten fester
10/29Principales informations avant-Bourse
10/29Morning Briefing - Markt Schweiz
10/29POLYPHOR : les actionnaires valident la fusion avec Enbiotix
More news
Press releases
06/28POLYPHOR : provides update on the Phase III FORTRESS study of balixafortide in patients wi..
EQ
06/28Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients W..
GL
06/08POLYPHOR HOSTING KEY OPINION LEADER : The Need for Novel Therapies for Severe Infections ..
EQ
06/08POLYPHOR HOSTING KEY OPINION LEADER : The Need for Novel Therapies for Severe Infections ..
GL
06/01POLYPHOR : balixafortide demonstrates consistent dual action anti-viral and anti-inflammat..
EQ
More press releases
Upcoming event on POLYPHOR AG